Aclarion Names Greg Gould as CFO
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 02 2025
0mins
Source: Globenewswire
Appointment of New CFO: Aclarion, Inc. has appointed Greg Gould as Chief Financial Officer, succeeding John Lorbiecki, who is retiring. Gould brings over 30 years of experience in public and private companies, focusing on growth and shareholder value.
Company's Focus and Technology: Aclarion is a healthcare technology firm that utilizes biomarkers and AI algorithms to assist physicians in identifying chronic low back pain. Their Nociscan platform is the first evidence-supported SaaS solution designed to differentiate between painful and nonpainful lumbar discs.
Analyst Views on CWEB
Wall Street analysts forecast CWEB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CWEB is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 43.980
Low
Averages
High
Current: 43.980
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
